Three companies announced COVID-19 programs Monday aimed at blocking the excessive inflammatory response seen in severe cases. Alexion unveiled a global program for its C5 inhibitor Ultomiris, while 4D pharma moved its live biotherapeutic therapy closer to the clinic, and Cyclacel partnered with the University of Edinburgh to test its pair of apoptosis regulators. The […]

What should be the Panthers strategy going into the NFL Draft? Writer and Analyst for Pro Football Focus discussed on Wilson & Parcell […]

EARLY IN THE evening on March 19, the prominent Silicon Valley investor and serial entrepreneur Balaji Srinivasan kicked off a tweet storm with a techno-libertarian call to arms: “To all biotech & tech people: The Manhattan Project for the virus is going to end up being the Palo Alto Project. It’s on us. The state doesn’t have tech […]